Esophageal cancer in China: Practice and research in the new era
International Journal of Cancer · 2023-05 · 152 (9) · 1741-1751
DOI: 10.1002/ijc.34301 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 05.10.2022. Verfasst von Hongcheng Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: International Cooperation, Esophageal Neoplasms. Die Arbeit wurde bisher 244-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Society of Clinical Oncology, National Natural Science Foundation of China.
Abstract (Originalsprache)
China, as the one of the largest developing countries in the world and with about one‐fifth of the global population, is bearing an increasing burden on health from cancer. In the area of esophageal cancer (EC), China accounts for more than 50% of the global cases, with this disease being a particularly worse for those in disadvantaged populations. Along with China's socioeconomic condition, the epidemiology, diagnosis, therapeutics and research of EC have developed throughout the 21st century. In the current review, existing control measures for EC in China are outlined, including the incidence, mortality, screening, clinical diagnosis, multidisciplinary treatment and research landscape. EC in China are very different from those in some other parts of the world, especially in Western countries. Core measures that could contribute to the prevention of EC and improve clinical outcomes in patients of less developed countries and beyond are recommended. International cooperation among academia, government and industry is especially warranted in global EC control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
- Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Gastroenterology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.
- Department of Cancer Prevention, Fudan University Shanghai Cancer Center, Shanghai, China.
ORCID-Profile: Hongcheng Zhu
Förderung
- Chinese Society of Clinical Oncology
- National Natural Science Foundation of China
Zitieren
APA
Zhu, H., Ma, X., Ye, T., Wang, H., Wang, Z., Liu, Q., & Zhao, K. (2023). Esophageal cancer in China: Practice and research in the new era. International Journal of Cancer, 152(9), 1741-1751. https://doi.org/10.1002/ijc.34301
Vancouver
Zhu H, Ma X, Ye T, Wang H, Wang Z, Liu Q, et al. Esophageal cancer in China: Practice and research in the new era. International Journal of Cancer. 2023;152(9):1741-1751. doi:10.1002/ijc.34301
BibTeX
@article{Zhu2023,
author = {Zhu, Hongcheng and Ma, Xiao and Ye, Ting and Wang, Honggang and Wang, Zezhou and Liu, Qi and Zhao, Kuaile},
title = {Esophageal cancer in China: Practice and research in the new era},
journal = {International Journal of Cancer},
year = {2023},
volume = {152},
number = {9},
pages = {1741--1751},
doi = {10.1002/ijc.34301}
}
EUVIMED